BOOKS AND ARTICLES ON PATIENT REPORTED OUTCOMES

A. GENERAL REVIEWS
B. HEALTH-RELATED QUALITY OF LIFE
C. PREFERENCE/UTILITIES

A. GENERAL REVIEWS
 
  1. Rapier CM (1996). An Introduction to Outcomes research. Brookwood Medical Publications, Surrey UK: Brookwood Medical Publications 1996..
    Review
     
  2. Spilker B. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, Lippincott-Raven, 1996.
    Review
     
  3. urke L. “Guidance for Industry: Patient-reported outcome measures: use in Medical Product Development to Support Labeling Claims: draft guidance.” Health Qual Life Outcomes. Oct 11, 2006;4:79.
B. HEALTH-RELATED QUALITY OF LIFE
 
  1. PROQOLID: Patient-Reported Outcome and Quality of Life Instruments Database
    Description: Developed by Mapi Research Institute and managed by Mapi Research Trust (Lyon, France), PROQOLID aims to identify and describe PRO (Patient Reported Outcomes) and QOL (Quality of Life) instruments to help you choose appropriate instruments and facilitate your access to them.
    www.qolid.org
     
  2. IQOD – International Health Related Quality of Life Databases.
    ISOQOL - International Society for Quality of Life Research
    www.iqola.org/links.aspx
    World Health Organization (WHO) WHO Behavioral Risk Factor Surveillance Program
    www.cdc.gov/hrqol/resources.htm
     
  3. OLGA (The On-Line guide to Quality of Life Assessment)
    Description: Databases with decision-theoretic selection algorithms to assist in the selection of instruments. Output: detailed descriptions of instruments and citations to relevant empirical studies.
    www.olga-qol.com
     
  4. Maurice J. Staquet, Ron D. Hayes, Peter M. Fayers. Quality of Life Assessment in Clinical Trials. Oxford University Press, 1998.
     
  5. Bram Kirshner and Gordon Guyatt. A Methodological Framework for Assessing Health Indices.
    Journal of Chronic Disease Vol.38, No.1, pp27-36, 1985.
    PMID: 3972947 [PubMed - indexed for MEDLINE]
    Review
     
  6. Gordon H. Guyatt, Claire Bombadier, Peter X. Tugwell. Measuring Disease-Specific Quality of Life in Clinical Trials. CMAJ 1986; 134(8):889-895.
    PMID: 3955482 [PubMed - indexed for MEDLINE]
    Review
     
  7. David L. Streiner and Geoffrey R. Norman. Health Measurement Scales: A Practical Guide to Their Development and Use (2nd Edition). New York: Oxford University Press, 1995.
     
  8. Guyatt G, Feeny D, and Patrick D. Issues in quality of life measurement in clinical trials. Controlled Clinical Trials 1991; 12:81S-90S.
     
  9. Hayes RD, Anderson R, and Revicki DA. (1995). Psychometric evaluation and interpretation of health-related quality of life data.In: Shumaker SA, Waughton MJ. The International Assessment of Health-Related Quality of Life: Theory, Translation, Measurement and Analysis. Oxford, England: Rapid Communications, 1995.
     
  10. Construction of Multi-Item Measures: The Theory of Measurement Error. In: Nunnally JC. Psychometric theory, (2nd edition), pp. 229-46. New York: McGraw HIll, 1978.
     
  11. German: Peterman F (ed.): Lebensqualität und chronische Krankheit, Dustri, München 1996.
    Review
     
  12. Guyatt GH, Feeny DH, Patrick DL. “Measuring health-related quality of life.” Ann Intern Med. Apr 15, 1993;118(8):622-9.
     
  13. Guyatt GH, Naylor DC, Dphil JE. “Users’ Guides to the Medical Literature. XII. How to Use Articles About Health-Related Quality of Life. Evidence-Based Medicine Working Group.” JAMA. Apr 16, 1997;277(15):1232-7.
     
  14. Leidy NK, Revicki DA, Geneste B. “Recommendations for Evaluating the Validity of Quality of Life Claims for Labeling and Promotion.” Value Health. Mar-Apr 1999;2(2):113-27.
     
  15. Martin BC, Ricci JF, Misra S, et al. “Measuring Quality of Life: A Primer for Managed Care Pharmacists.” Journal of Managed Care Pharmacy. July/Aug 1996;2(4):415-19.
     
  16. Measuring Health: A Guide to Rating Scales and Questionnaires by Ian McDowell, 3rd Edition 2006, Oxford University Press.

TOP

C. PREFERENCE/UTILITIES
 
  1. Torrance GW, Furlong W, Feeny D. Health Utility Estimation. Expert Review of Pharmacoeconomics Outcomes Research 2002;2(2):99-108.
    Review
     
  2. Mullins CD. “The Visibility and Divisibility of Quality-adjusted Life Years.” Clin Ther. Aug 2005;27(8):1276-7.
     
  3. Raisch DW. “Understanding Quality-Adjusted Life Years and their application to pharmacoeconomic research.” The Annals of Pharmacotherapy. Jul/Aug 2000;34(7):906-914.

TOP


Educator's Tool Kit main page
 

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2008 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.
 
Website design by Eagle Systems USA, Inc.